![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
M.D. Anderson Cancer Center |
---|---|
Information provided by: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT00502177 |
The overall objective of this prospective study is to provide a descriptive analysis of the quality of life of pediatric cancer patients enrolled on M.
D. Anderson Cancer Center Protocol 2005-0917, "A Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) with Escalating Doses of Cisplatin for Children with Peritoneal Carcinomatosis or Advanced Peritoneal and Retroperitoneal Disease".
Condition | Intervention |
---|---|
Peritoneal Neoplasms |
Behavioral: Questionnaire |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Official Title: | Quality of Life Questionnaire for Pediatric Patients Undergoing Continuous Hyperthermic Peritoneal Perfusion With Cisplatin |
Estimated Enrollment: | 34 |
Study Start Date: | June 2007 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
1
Patients undergoing continuous hyperthermic peritoneal perfusion with cisplatin and their parents/caregivers.
|
Behavioral: Questionnaire
Questionnaires taking a total of 10 minutes to complete.
|
Ages Eligible for Study: | up to 18 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Patients undergoing continuous hyperthermic peritoneal perfusion with cisplatin and their parents/caregivers.
Inclusion Criteria:
Exclusion Criteria:
Contact: Holly L. Green, BS | 713-745-1818 |
United States, Texas | |
U.T.M.D. Anderson Cancer Center | Recruiting |
Houston, Texas, United States, 77030 | |
Principal Investigator: Holly L. Green, BS |
Principal Investigator: | Holly L. Green, BS | U.T.M.D. Anderson Cancer Center |
Responsible Party: | U.T.M.D. Anderson Cancer Center ( Holly L. Green, BS/Physician Assistant ) |
Study ID Numbers: | 2006-1106 |
Study First Received: | July 16, 2007 |
Last Updated: | December 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00502177 History of Changes |
Health Authority: | United States: Institutional Review Board |
Continuous Hyperthermic Peritoneal Perfusion Peritoneal Neoplasms Quality of Life |
Questionnaire Survey CHPP |
Fever Digestive System Diseases Digestive System Neoplasms Cisplatin Peritoneal Diseases |
Quality of Life Gastrointestinal Neoplasms Peritoneal Neoplasms Abdominal Neoplasms |
Neoplasms Digestive System Diseases Digestive System Neoplasms Neoplasms by Site |
Peritoneal Diseases Peritoneal Neoplasms Abdominal Neoplasms |